THE ANALYSIS OF MICRONUCLEI FREQUENCY IN A CONTROL SAMPLE, AND IN HORMONALLY- TREATED FEMALE PATIENTS ATTENDING THE KRAGUJEVAC HOSPITAL, SERBIA, YUGOSLAVIA
Milosevic-Djordjevic O1, Grujicic D1, Marinkovic D2, Arsenijevic S3, Joksic G4, Jankovic S5
*Corresponding Author: Dr. Olivera Milosevic-Djordjevic, Faculty of Sciences, University of Kragujevac, Institute of Biology, Department of Genetics, Radoja Domanovica 12, P.O. Box 60, 34000 Kragujevac, Serbia, Yugoslavia; Tel: +381-34-336-223 to 330; Fax: +381-34-335-040; E-mail: darko@knez.uis.kg.ac.yu
page: 37

INTRODUCTION

Micronuclei (MN) in cells undergoing mitosis arise from structural chromosomal aberrations or disturbed function of the mitotic spindle. Some authors consider that MN frequencies in peripheral blood lymphocytes of human individuals provide an effective estimate of the effects of physical and chemical factors [1]. This test permits an analysis of a great number of lymphoblasts per sample, which is important for a more realistic picture of the cell’s cytogenetic damage, as well as for the discovery of genotoxic effects in tested preparations [2-4]. In previous papers [5,6], we have shown that gestagens (progesterone and its derivatives) induce a significant increase of MN frequency in female patients who maintained their pregnancies by taking these preparations, as well as in their newborns.

Progesterone and its derivatives are a significant group of medicines with an important application in the prevention of spontaneous abortions. A considerable quantity of progesterone changes the ultrastructure of uterus muscles, and in this way inhibits spontaneous contractions and the possibility of abortion [7]. Since they are frequently used, and their activity is realized by direct influence on DNA molecules [8], the need arises to test these preparations for genotoxicity. The aim of this study was the determination of average MN frequency in dependence on gestagen type, as well as to show variability of frequencies of this phenotypical characteristic by the application of analysis of variance (ANOVA).




Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006